Figure 10.
GSTM1 expression in the first healthy volunteer (HV1) after sulforaphane (SFN) supplement consumption at 12.6 mg for the first day (T1), 25.2 mg for the second and third days (T2) and 25.2 mg for further seven days (T3) (a) and 90 mg/day for three days (b). Data are reported as 2−ΔΔCt values considering the no assumption samples (T0) as calibrators and using GAPDH housekeeping gene as reference.